MAP2K1 Gene Cardiofaciocutaneous Syndrome Type 3 Genetic Test sale cost 4400 AED
TIMP1 Gene Bicuspid Aortic Valve Genetic Test sale cost 4400 AED TIMP1 Gene Bicuspid Aortic Valve Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
PSEN1 Gene Cardiomyopathy dilated type 1U Genetic Test sale cost 4400 AED PSEN1 Gene Cardiomyopathy dilated type 1U Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MAP2K1 Gene Cardiofaciocutaneous Syndrome Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MAP2K1 Gene Cardiofaciocutaneous Syndrome Type 3 Genetic Test” is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the MAP2K1 gene, which are associated with Cardiofaciocutaneous Syndrome Type 3 (CFC3). This rare genetic disorder is characterized by distinctive facial features, heart defects, skin abnormalities, and developmental delays. The test is crucial for early diagnosis and management of the syndrome, providing vital information for personalized treatment plans and family planning.

Performed through a simple blood sample or cheek swab, the test examines the MAP2K1 gene for specific mutations known to cause CFC3. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify these genetic variations. DNA Labs UAE, known for its state-of-the-art facilities and highly qualified geneticists, ensures a reliable and efficient testing process, making it a trusted choice for patients and healthcare providers seeking comprehensive genetic analysis for Cardiofaciocutaneous Syndrome Type 3.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MAP2K1 Gene Cardiofaciocutaneous Syndrome Type 3 Genetic Test

At DNA Labs UAE, we offer the MAP2K1 Gene Cardiofaciocutaneous Syndrome Type 3 Genetic Test. This test is designed to identify any mutations or variations in the MAP2K1 gene that are associated with Cardiofaciocutaneous Syndrome Type 3 (CFC3).

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the MAP2K1 Gene Cardiofaciocutaneous Syndrome Type 3 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by CFC3. This will help in identifying any potential genetic mutations or variations in the MAP2K1 gene.

Test Details

The MAP2K1 gene is associated with Cardiofaciocutaneous Syndrome Type 3 (CFC3), a rare genetic disorder that affects the development of the heart, face, and skin. Our NGS (Next-Generation Sequencing) genetic testing technique allows us to analyze multiple genes simultaneously and detect any mutations or variations within them. Specifically, for CFC3, we can focus on the MAP2K1 gene and identify any associated mutations or variations.

By performing the NGS genetic test for the MAP2K1 gene, our healthcare professionals can confirm a diagnosis, predict disease progression, and provide appropriate medical management and genetic counseling for affected individuals and their families. This information is crucial for understanding the genetic basis of CFC3 and developing personalized treatment plans.

Test Name MAP2K1 Gene Cardiofaciocutaneous syndrome type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MAP2K1 Gene Cardiofaciocutaneous syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAP2K1 Gene Cardiofaciocutaneous syndrome type 3 NGS Genetic DNA Test gene MAP2K1
Test Details

The MAP2K1 gene is associated with Cardiofaciocutaneous syndrome type 3 (CFC3), which is a rare genetic disorder characterized by various developmental abnormalities affecting the heart, face, and skin.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify any mutations or variations within them. In the case of CFC3, NGS can be used to specifically analyze the MAP2K1 gene and detect any mutations or variations that may be present.

By performing an NGS genetic test for the MAP2K1 gene, healthcare professionals can determine if an individual has any mutations or variations in this gene that are associated with CFC3. This information can help in confirming a diagnosis, predicting disease progression, and providing appropriate medical management and genetic counseling for affected individuals and their families.

SKU: TEST-3353 Category:

Related products